+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Biopreservation Market Research and Forecast, 2019-2025

  • ID: 4757167
  • Report
  • Region: Global
  • Orion Market Research Private Limited
until Aug 31st 2019
1 of 3


  • Amgen, Inc.
  • BioLife Solutions, Inc.
  • Brooks Life Sciences
  • Chart Industries, Inc.
  • Lifeline Scientific, Inc.
  • PrecisionMed, Inc.
  • MORE
Global Biopreservation Market, Size, Share & Trends Analysis Report, by Application (Drug Discovery, Regenerative Medicine, and Bio Banking), by Cell Provider (Tumor Cells, Mesenchymal Stem Cells, Human Embryonic Stem Cells and Other Cells), by End-User (Hospitals, Bio Banks and Gene Banks) and Forecast, 2019-2025.

Cellular therapies are sourced by biological materials or known as living drugs, which require specialized biological support, therefore, biopreservation are used to maintain optimal recovery, viability and post-preservation. The biopreservation enables to optimize a multitude of parameters, such as storage temperature and cooling/thawing rates based on the biophysics of the specific cell. The biopreservation is used in Good Manufacturing Practices (GMP), cell therapy products or clinical manufacturing process, such as isotonic and home-brew may not be compatible in the process. The biopreservation is long-term preservation technique, which supports in preserving functionality and integrity of cells, tissues, and organs. There is an increase in chronic human diseases such as cardiovascular and neurodegenerative diseases. Therefore, the development of novel therapies and approaches are needed to extend life expectancy. The living cells as smart drugs are used to treat chronic diseases, as it targets specific tissues to rescue organ function.

As living drugs, cell therapies need to be effective for preserving small molecules and monoclonal antibodies and fulfil the need for cellular support during product life cycle, and optimize strategies such as by maintaining viable efficacy of cell therapies during collection, manufacturing and delivery stages. The biopreservation technique is emerged with manufacturing scale-up. The cryopreservation of stem cells is more complex to preserve than normothermic cell models. Biopreservation enables to maintain health and function, suppress degradation of biological materials outside the body. In commercial cell therapy products, biopreservation offers flexibility in manufacturing and shipping, facilitate effective process development, and reduces manufacturing costs. Further, biopreservation protocol maintains biological function during product lifecycle, offers needle-to-needle from the time of sample collection from the donor, to administer to the recipient.

There are various companies involved in the biopreservation market such as BioLife Solutions Inc., Cesca Therapeutics Inc., Sigma-Aldrich Corp., QIAGEN N.V., Thermo Fisher Scientific, Inc., PHC Corp., VWR International, Inc. and Biomatrica, Inc. The companies are focused on developing biopreservation products and solutions to stay competitive in the market. For Instance, Sigma Aldrich offers biopreservation products, such as CryoStor which is a cell cryopreservation media, which support to optimize preservation media. During the cryopreservation process, the molecular biological aspects of the cells, reduces cryopreservation-induced delayed-onset cell death and improvise post-thaw cell viability and function. During the techniques for thawing biological materials from cryogenic conditions, care must be taken to prevent damage or cell death. In thawing water baths or electric heating devices are used. The other thawing devices include THAWSTAR Automated Cryogenic Vial Thawing System from BioCision LLC, BARKEY plasmatherm from Barkey GmbH & Co. The BioLife Solutions offers HypoThermosol biopreservation media, which is used to optimize hypothermic storage and shipping media product. HypoThermosol is serum free and protein free biopreservation media that offers maximum storage and shipping stability for biologics at 2-8°C.

Geographically, the market is divided into North America, Europe, Asia-Pacific and Rest of the World. North America region dominates the global biopreservation market due to an increase in drug discovery and various therapies in biomedical research. Europe is the second largest market due to the technological advancement, whereas, Asia-Pacific is the fastest growing market due to increasing demand of biopreservation and biobanking. There are huge advancements for biopreservation technique such as a change in formulation of hypothermic storage solutions, next-generation cryopreservation solutions, and design and integration with nanoscale technologies. Geographical expansion, merger & acquisition, finding a new market or innovate in their core competency in order to expand individual market share are the key strategies adopted by major market players.

Research Methodology

The market study of the global biopreservation market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary Sources Include:
  • Financial reports of companies involved in the market
  • Authentic public databases
  • Whitepapers, research-papers and news blogs
  • Company websites and their product catalog
The report is intended for biobanks, research organizations, biotechnology companies, investment companies, government organizations for overall market analysis and competitive analysis. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models delivering insights into the market for better business decisions.

Market Segmentation:

1. Global Biopreservation Market Research and Analysis by Product
2. Global Biopreservation Market Research and Analysis by Application
3. Global Biopreservation Market Research and Analysis by Cell provider
4. Global Biopreservation Market Research and Analysis by End-User

The Report Covers:
  • Comprehensive research methodology of the global biopreservation market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global biopreservation market.
  • Insights about market determinants which are stimulating the global biopreservation market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown
2 of 3


  • Amgen, Inc.
  • BioLife Solutions, Inc.
  • Brooks Life Sciences
  • Chart Industries, Inc.
  • Lifeline Scientific, Inc.
  • PrecisionMed, Inc.
  • MORE
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders

2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations

3. Competitive Landscape
3.1. Competitive Dashboard
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. BioLife Solutions, Inc. Overview Financial Analysis SWOT Analysis Recent Developments
3.3.2. Thermo Fisher Scientific, Inc. Overview Financial Analysis SWOT Analysis Recent Developments
3.3.3. QIAGEN N.V. Overview Financial Analysis SWOT Analysis Recent Developments
3.3.4. Chart Industries, Inc. Overview Financial Analysis SWOT Analysis Recent Developments
3.3.5. PHC Corp. Overview Financial Analysis SWOT Analysis Recent Developments

4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities

5. Market Segmentation
5.1. Global Biopreservation Market by Product
5.1.1. Equipment Freezers Refrigerators Temperature Maintaining Units Other (Vials, Microtiter Plates)
5.1.2. Consumables Nutrient Media Sera
5.2. Global Biopreservation Market by Application
5.2.1. Drug Discovery
5.2.2. Regenerative Medicine (Cell Therapy, Gene Therapy)
5.2.3. Bio Banking (Human Eggs/Sperm, IVF)
5.3. Global Biopreservation Market by Cell Provider
5.3.1. Tumor Cells
5.3.2. Mesenchymal Stem Cells
5.3.3. Human Embryonic Stem Cells
5.3.4. Other Cells
5.4. Global Biopreservation Market by End-User
5.4.1. Hospitals
5.4.2. Bio Banks
5.4.3. Gene Banks

6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World

7. Company Profiles
7.1. Amgen, Inc.
7.2. BioLife Solutions, Inc.
7.3. Biomatrica, Inc.
7.4. BioCision LLC
7.5. Brooks Life Sciences
7.6. Cesca Therapeutics, Inc.
7.7. Custom Biogenic Systems, Inc.
7.8. VWR International LLC
7.9. Chart Industries, Inc.
7.10. LabVantage Solutions, Inc.
7.11. PHC Corp.
7.12. PrecisionMed, Inc.
7.13. ProMedDx, LLC
7.14. Provia Laboratories, LLC
7.16. Thermo Fisher Scientific, Inc.
7.17. QIAGEN N.V.
7.18. Sigma-Aldrich Corp.
7.19. Lifeline Scientific, Inc.
7.20. Hamilton Company
Note: Product cover images may vary from those shown
3 of 3


4 of 3
  • Amgen, Inc.
  • BioLife Solutions, Inc.
  • Biomatrica, Inc.
  • BioCision LLC
  • Brooks Life Sciences
  • Cesca Therapeutics, Inc.
  • Custom Biogenic Systems, Inc.
  • VWR International LLC
  • Chart Industries, Inc.
  • LabVantage Solutions, Inc.
  • PHC Corp.
  • PrecisionMed, Inc.
  • ProMedDx, LLC
  • Provia Laboratories, LLC
  • Thermo Fisher Scientific, Inc.
  • Sigma-Aldrich Corp.
  • Lifeline Scientific, Inc.
  • Hamilton Company
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4757167